Daniela Di Carlo

6PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersAdolescent healthImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 08, 2024
Clinicopathological Analysis of a European Cohort of MYOD1 Mutant Rhabdomyosarcomas in Children and Young Adults.

Julia C Chisholm, Joanna L Selfe, Rita Alaggio

|Apr 29, 2024
Treatment at relapse for synovial sarcoma of children and adolescents: A multi-institutional European retrospective analysis.

Andrea Ferrari, Daniel Orbach, Luca Bergamaschi

|Oct 19, 2023
Inflammatory Myofibroblastic Tumor With ROS1 Gene Fusions in Children and Young Adolescents.

Reineke A Schoot, Daniel Orbach, Veronique Minard Colin

|Aug 12, 2023
Maintenance Chemotherapy for Patients with Rhabdomyosarcoma.

Gianni Bisogno, Veronique Minard-Colin, Meriel Jenney

|Aug 23, 2021
PAX3-NCOA1 alveolar rhabdomyosarcoma of the tongue: A rare entity with challenging diagnosis and management.

Daniela Di Carlo, Cyrus Chargari, Jean-Yves Scoazec

|Aug 07, 2019
Prognostic role of pleural effusion or ascites in localized rhabdomyosarcoma.

Daniela Di Carlo, Andrea Ferrari, Tiziana Toffolutti

Pageof 1

Frequent Collaborators

4 joint publications

Andrea Ferrari

4 joint publications

Giuseppe Maria Milano

3 joint publications

Daniel Orbach

2 joint publications

Max M van Noesel